Published ahead of print on February 18, 2010, doi:10.1164/rccm.200907-1166OC Am. J. Respir. Crit. Care Med., Volume 181, Number 12, June 2010, 1310-1317 A more recent version of this article appeared on June 15, 2010
Submitted on July 30, 2009 Knocking-down Cav1 Calcium Channels Implicated in Th2-cell Activation Prevents Experimental AsthmaMarilena Djata Cabral1,1 Centre de Physiopathologie de Toulouse Purpan, Institut National de la Santé et de la Recherche Médicale (INSERM), U563, Toulouse, France; Université Paul Sabatier, Toulouse, France; Institut Fédératif de la Recherche Bio-Médicale de Toulouse (I.F.R.-B.M.T.), Tolouse, France; L’institut du thorax, Equipe AVENIR, INSERM U915, Nantes, France; Faculté de Médecine, Université de Nantes, Nantes, France; L’institut du thorax, Service de Pneumologie, Plate-Forme Transversale d’Allergologie, CHU Nantes, Nantes, France, 2 Centre de Physiopathologie de Toulouse Purpan, Institut National de la Santé et de la Recherche Médicale (INSERM), U563, Toulouse, France; Université Paul Sabatier, Toulouse, France; Institut Fédératif de la Recherche Bio-Médicale de Toulouse (I.F.R.-B.M.T.), Tolouse, France, 3 Centre de Physiopathologie de Toulouse Purpan, Institut National de la Santé et de la Recherche Médicale (INSERM), U563, Toulouse, France; Université Paul Sabatier, Toulouse, France; Institut Fédératif de la Recherche Bio-Médicale de Toulouse (I.F.R.-B.M.T.), Tolouse, France; CNRS Groupement de recherche GDR 2688, Toulouse, France, 4 Université Paul Sabatier, Toulouse, France; Centre de Biologie du Développement, Centre National de la Recherche Scientifique CNRS UMR 5547, Toulouse, France; CNRS Groupement de recherche GDR 2688, Toulouse, France, 5 L’institut du thorax, Equipe AVENIR, INSERM U915, Nantes, France; Faculté de Médecine, Université de Nantes, Nantes, France; L’institut du thorax, Service de Pneumologie, Plate-Forme Transversale d’Allergologie, CHU Nantes, Nantes, France, 6 INSERM, U844, Montpellier, France, 7 Centre de Physiopathologie de Toulouse Purpan, Institut National de la Santé et de la Recherche Médicale (INSERM), U563, Toulouse, France; Université Paul Sabatier, Toulouse, France; Institut Fédératif de la Recherche Bio-Médicale de Toulouse (I.F.R.-B.M.T.), Tolouse, France; Centre Hospitalier Universitaire, Toulouse, France, 8 Centre de Physiopathologie de Toulouse Purpan, Institut National de la Santé et de la Recherche Médicale (INSERM), U563, Toulouse, France; Université Paul Sabatier, Toulouse, France; Institut Fédératif de la Recherche Bio-Médicale de Toulouse (I.F.R.-B.M.T.), Tolouse, France; CNRS Groupement de recherche GDR 2688, Toulouse, France; Centre Hospitalier Universitaire, Toulouse, France * To whom correspondence should be addressed. E-mail: Lucette.Pelletier{at}inserm.fr.
Rationale: T helper 2 (Th2)-cells orchestrate allergic asthma and the cytokines they produce, interleukin (IL)-4, IL-5 and IL-13 are deleterious in allergy. Therefore, it is important to identify key signaling-molecules expressed by Th2-cells that are essential for their function. We have previously shown that dihydropyridines selectively modulate Th2-cell functions. Objectives: Since dihydropyridines bind to and modulate voltage-dependent calcium (Cav1) channel in excitable cells, we aimed at showing that Th2-cells selectively express functional Cav1-related channels, the inhibition of which may prevent asthma. Methods: We looked for Cav1 channel expression in Th2 and Th1-cells by real-time PCR and Western blotting. We sequenced the isoforms expressed by Th2-cells and tested whether Cav1 antisense oligodeoxynucleotides (Cav1AS) affected Ca2+ signaling and cytokine production. Finally, we tested the effect of Cav1AS in the passive asthma model by injection of ovalbumin (OVA)-specific Th2-cells transfected with Cav1AS into BALB/c mice challenged with intranasal OVA and in the active model of asthma by intranasal delivery of Cav1AS together with soluble asthma in BALB/c mice previously immunized with OVA in alum. Measurement and main results: We show that mouse Th2 but not Th1-cells expressed Cav1.2 and Cav1.3 channels. Th2-cells transfected with Cav1AS had impaired Ca2+ signaling and cytokine production, and lost their ability to induce airway inflammation upon adoptive transfer. Furthermore, intranasal administration of Cav1AS suppressed airway inflammation and hyper-reactivity in an active model of asthma. Conclusions: These results indicate that Th2-cells selectively express Cav1 channels that may be efficiently targeted in T-lymphocytes to prevent experimental asthma. Key words: Th2-cells voltage-dependent calcium channels allergic asthma antisense oligonucleotides
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||